Randomized multicenter phase II trial evaluating the sequencing of PD-1 inhibition with pembrolizumab (ppembro) and standard platinum-based chemotherapy (chemo) in patients (pts) with metastatic non-small cell lung cancer (NSCLC) AFT-09 (Alliance)
- Citation:
- J Clin Oncol vol 37 (15_suppl)
- Meeting Instance:
- ASCO 2019
- Year:
- 2019
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- AFT
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 3531
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- Thomas Hensing Xiaofei Wang David Kozono Arkadius Dudek Stephen Graziano Jyoti Patel Bryan Faller Konstantin Dragnev Everett Vokes Thomas Stinchcombe
- Networks:
- HEARTLAND, IL018, LAPS-IL036, LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-NC010, LAPS-NH012, NY141
- Study
- AFT-09
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: